This Week Health
Alex's Lemonade Stand This Week Health
<- Back to Insights
May 22, 2024

Thoma Bravo-Owned LogRhythm Announces Merger With Rival Exabeam

publication
|
Summary
LogRhythm, owned by private equity firm Thoma Bravo, has announced a merger with its SIEM market competitor Exabeam. Financial details were not disclosed, but Exabeam's latest valuation was $2.5 billion. The merger aims to leverage complementary strengths in AI-driven threat detection, investigation, and response, offering enhanced R&D, product innovation, and expanded support. Exabeam provides a SIEM platform known for its behavioral analytics and automated threat response capabilities. The deal is anticipated to close in Q3 2024, pending regulatory approvals.

Explore Related Topics

Subscribe Now

Receive 7 Top Stories Daily
Subscribe News
Healthcare Transformation Powered by Community

© Copyright 2024 Health Lyrics All rights reserved